Any stock, in context
GLAXO · Healthcare
Glaxosmithkline Pharmaceuticals Ltd.
Observation · 15 Oct 2026
How these are readGlaxosmithkline Pharmaceuticals closed at ₹2,524.7 on 15 Oct 2026, 1.8% above its 200-day average and 9.9% below its 50-day average: above the long line, below the short one. It sits 18.7% below its highest close of the past year, in the middle fifth of its one-year range. Over three months it rose 2.8%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +1.8%
- the long line
- vs 50-day
- −9.9%
- the short line
- From 52w high
- −18.7%
- ₹2,088.1₹3,120.7
- 3 months
- +2.9%
- sector median −2.7% · 55 of 146
Nifty Midcap 150 · Healthcare · EQ series · median traded value ₹16 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −0.56%
- 1W
- –
- 1M
- −10.44%
- 3M
- +2.85%
- YTD
- –
- 1Y
- −5.36%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.